Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection

[1]  P. Neuhaus,et al.  The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors , 2001, Journal of Cancer Research and Clinical Oncology.

[2]  X. Shu,et al.  Epidemiological study of urinary 6beta-hydroxycortisol to cortisol ratios and breast cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  F. Berrino,et al.  Estrogen Metabolism and Risk of Breast Cancer: a Prospective Study of the 2:16␣-hydroxyestrone Ratio in Premenopausal and Postmenopausal Women , 2022 .

[4]  C. Longcope,et al.  Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  C. Rock,et al.  Eating pathology and obesity in women at risk for breast cancer recurrence. , 2000, The International journal of eating disorders.

[6]  X. Shu,et al.  Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  J. Holtzman,et al.  Within-person variability of the ratios of urinary 2-hydroxyestrone to 16α-hydroxyestrone in Caucasian women☆ , 1999, Steroids.

[8]  J. Manson,et al.  Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  G. Carruba,et al.  Re: Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. , 1999, Journal of the National Cancer Institute.

[10]  G. Murray,et al.  Immunohistochemical Localization of Cytochrome P450 CYP1B1 in Breast Cancer with Monoclonal Antibodies Specific for CYP1B1 , 1999, Journal of Histochemistry and Cytochemistry.

[11]  C. Rock,et al.  Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group. , 1999, Journal of the American Dietetic Association.

[12]  M. Pike,et al.  Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. , 1999, Journal of the National Cancer Institute.

[13]  K. Westerlind,et al.  The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: Implications for disease-risk assessment , 1999, Steroids.

[14]  N. Roodi,et al.  Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. , 1998, Cancer research.

[15]  L. Kuller,et al.  Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. , 1998, British Journal of Cancer.

[16]  J. Manson,et al.  Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. , 1998, Journal of the National Cancer Institute.

[17]  T. Klug,et al.  Application of an improved ELISA assay to the analysis of urinary estrogen metabolites , 1998, Steroids.

[18]  F. Guengerich,et al.  16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5. , 1998, Carcinogenesis.

[19]  G. Ho,et al.  Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. , 1998, Annals of the Academy of Medicine, Singapore.

[20]  K. Patil,et al.  Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Sparano,et al.  Urinary estrogen metabolites and breast cancer: a case-control study. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  E. Winer,et al.  Weight gain in women diagnosed with breast cancer. , 1997, Journal of the American Dietetic Association.

[23]  E. Winer,et al.  Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. , 1997, The American journal of clinical nutrition.

[24]  J. Liehr.  Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. , 1997, Environmental health perspectives.

[25]  H. Keizer,et al.  4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer. , 1997, Fertility and sterility.

[26]  M. Osborne,et al.  2-hydroxyestrone: the 'good' estrogen. , 1996, The Journal of endocrinology.

[27]  J. Clausen,et al.  Effects of dietary broccoli on human in vivo drug metabolizing enzymes: evaluation of caffeine, oestrone and chlorzoxazone metabolism. , 1996, Carcinogenesis.

[28]  J. Li,et al.  Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation. , 1995, Cancer research.

[29]  Michael S. Pepper,et al.  The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth , 1994, Nature.

[30]  M. Osborne,et al.  Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. , 1993, Journal of the National Cancer Institute.

[31]  B. Nilsson,et al.  Treatment failure and dietary habits in women with breast cancer. , 1993, Journal of the National Cancer Institute.

[32]  H. Bradlow,et al.  Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. , 1986, The New England journal of medicine.

[33]  H. Bradlow,et al.  Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Anderson,et al.  Abnormal oxidative metabolism of estradiol in women with breast cancer. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Holtzman,et al.  Correspondence re: G. C. Kabat et al., Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol., Biomark. Prev., 6: 505-509, 1997. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  A. Conney,et al.  Functional role of estrogen metabolism in target cells: review and perspectives. , 1998, Carcinogenesis.

[37]  H. Keizer,et al.  Plasma 2-hydroxycatecholestrogen responses to acute submaximal and maximal exercise in untrained women. , 1997, Journal of applied physiology.

[38]  H. Marston,et al.  Food Composition Tables. , 1944 .